| Ytd | 19.53% | |
| 1y | -46.97% |
| Open | 0.80 | Prev Close | 0.79 | Low | 0.77 | High | 0.80 | Mkt Cap | 60.85M |
| Vol | 254.75K | Avg Vol | 324.60K | EPS | -1.02 | P/E | N/A | Forward P/E | -1.43 |
| Beta | 2.36 | Short Ratio | 1.75 | Inst. Own | 6.08% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.68 | 200-d Avg | 0.74 | 1yr Est | 6.50 |
Modular Regulatory Strategy Creates Defined Milestone Cadence, Enables Earlier FDA Engagement, and S
Modular Regulatory Strategy Creates Defined Milestone Cadence, Enables Earlier FDA Engagement, and S
Envoy Medical®, Inc. (NASDAQ:COCH) ("Envoy Medical"), a hearing health company pioneering fu
Termination Reflects Company's Confidence in Current Capital Position White Bear Lake, Minnesota--(N
ustralian and European Patent Offices Grant the Company Four Patents Relating to Key Innovations in
Envoy Medical (NASDAQ:COCH) reported quarterly losses of $(0.08) per share which beat the analyst co
Envoy Medical® Inc. (NASDAQ:COCH) ("Envoy Medical" or the "Company"), a hearing heal
Positive Initial 6-Month Data from First 10 Patients and Improvements in Speech Understanding and Qu
The first three pivotal trial patients implanted at the start of 2025 are now the first to reach the
Top Wall Street analysts changed outlook on top names. Needham downgrades CNTA, Baird downgrades PHR
Top analysts changed outlook on top names. For full view of changes, see analyst ratings page. Consi
HC Wainwright & Co. analyst Yi Chen initiates coverage on Envoy Medical (NASDAQ:COCH) with a
Envoy Medical (NASDAQ:COCH) reported quarterly losses of $(0.26) per share which beat the analyst co
Envoy Medical completes enrollment for its Acclaim cochlear implant trial, a fully implanted device
Financing was led by new investor and top-tier healthcare fund Nantahala Capital and longtime Envoy
Envoy Medical® Inc. (NASDAQ:COCH) ("Envoy Medical" or the "Company"), a hearing heal
Momentum continues to build for Company as series of clinical milestones are met, design choices cem
Envoy Medical® Inc. (NASDAQ:COCH) ("Envoy Medical" or the "Company"), a hearing heal
Shares of Byrna Technologies Inc. (NASDAQ: BYRN) rose sharply during Friday’s session after the comp
Shares of Okta, Inc. (NASDAQ: OKTA) shares rose sharply in today’s pre-market trading after the com